Cargando…
Development and Delphi validation of a Best Possible Medication History form
OBJECTIVE: To develop and validate a standardized Best Possible Medication History (BPMH) form that could be used by clinical pharmacists. METHODS: The draft version was presented to a focus group and was adapted following their comments. A three-rounds e-Delphi method was used to validate content,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986933/ https://www.ncbi.nlm.nih.gov/pubmed/35414586 http://dx.doi.org/10.1136/ejhpharm-2021-003095 |
_version_ | 1784901273169952768 |
---|---|
author | Hoornaert, Camille Pochet, Stéphanie Lorent, Sophie |
author_facet | Hoornaert, Camille Pochet, Stéphanie Lorent, Sophie |
author_sort | Hoornaert, Camille |
collection | PubMed |
description | OBJECTIVE: To develop and validate a standardized Best Possible Medication History (BPMH) form that could be used by clinical pharmacists. METHODS: The draft version was presented to a focus group and was adapted following their comments. A three-rounds e-Delphi method was used to validate content, usability and face validity of the BPMH form. We supplemented the quantitative analysis with a qualitative analysis of comments for each Delphi round. RESULTS: The draft BPMH form contained 23 items grouped into eight tabs. Refinement of these tabs and items by the focus group resulted in 7 tabs and 21 items, which were included in the Delphi survey. The consensus was obtained for all tabs within the second round (p=0.072). Consensus was reached on 76% (16/21) of items in the third round. 20 items were included following the qualitative analysis of the experts’ comments in the third round. CONCLUSIONS: The findings of this study provide data on the content of the BPMH form. This form can be used to help clinical pharmacists to collect a complete and accurate medication list on admission. It could have an impact on inpatient safety and improve inpatient management. Studies with an international e-Delphi should be conducted for wider use |
format | Online Article Text |
id | pubmed-9986933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-99869332023-03-07 Development and Delphi validation of a Best Possible Medication History form Hoornaert, Camille Pochet, Stéphanie Lorent, Sophie Eur J Hosp Pharm Original Research OBJECTIVE: To develop and validate a standardized Best Possible Medication History (BPMH) form that could be used by clinical pharmacists. METHODS: The draft version was presented to a focus group and was adapted following their comments. A three-rounds e-Delphi method was used to validate content, usability and face validity of the BPMH form. We supplemented the quantitative analysis with a qualitative analysis of comments for each Delphi round. RESULTS: The draft BPMH form contained 23 items grouped into eight tabs. Refinement of these tabs and items by the focus group resulted in 7 tabs and 21 items, which were included in the Delphi survey. The consensus was obtained for all tabs within the second round (p=0.072). Consensus was reached on 76% (16/21) of items in the third round. 20 items were included following the qualitative analysis of the experts’ comments in the third round. CONCLUSIONS: The findings of this study provide data on the content of the BPMH form. This form can be used to help clinical pharmacists to collect a complete and accurate medication list on admission. It could have an impact on inpatient safety and improve inpatient management. Studies with an international e-Delphi should be conducted for wider use BMJ Publishing Group 2023-03 2022-04-12 /pmc/articles/PMC9986933/ /pubmed/35414586 http://dx.doi.org/10.1136/ejhpharm-2021-003095 Text en © European Association of Hospital Pharmacists 2023. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Hoornaert, Camille Pochet, Stéphanie Lorent, Sophie Development and Delphi validation of a Best Possible Medication History form |
title | Development and Delphi validation of a Best Possible Medication History form |
title_full | Development and Delphi validation of a Best Possible Medication History form |
title_fullStr | Development and Delphi validation of a Best Possible Medication History form |
title_full_unstemmed | Development and Delphi validation of a Best Possible Medication History form |
title_short | Development and Delphi validation of a Best Possible Medication History form |
title_sort | development and delphi validation of a best possible medication history form |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986933/ https://www.ncbi.nlm.nih.gov/pubmed/35414586 http://dx.doi.org/10.1136/ejhpharm-2021-003095 |
work_keys_str_mv | AT hoornaertcamille developmentanddelphivalidationofabestpossiblemedicationhistoryform AT pochetstephanie developmentanddelphivalidationofabestpossiblemedicationhistoryform AT lorentsophie developmentanddelphivalidationofabestpossiblemedicationhistoryform |